top of page


The Gstaad Intelligence Brief: Where the Next $10B in Longevity Capital Will Flow
Direct macro intelligence synthesized from main-stage keynotes and private allocator dialogues at the seventh Longevity Investors Conference in Gstaad.
What Top Allocators at the Longevity Investors Conference Are Quietly Rotating Out Of—and the Sovereign Infrastructure Replacing It.
7 min read


NAD+: The Executive Molecule Shaping Longevity and Peak Performance
Imagine arriving at your office on a Monday morning, your schedule packed with high-stakes meetings, strategic decisions, and back-to-back travel. Yet, despite your accomplishments, something feels off: your energy dips, your focus wavers, and recovery from late nights seems slower than it used to be. For executives and high-performing leaders, these subtle declines are more than inconvenience—they are signals from your cells.
Enter NAD+ (Nicotinamide Adenine Dinucleotide),
2 min read
bottom of page




